


Vaxess Technologies Revenue
Pharmaceutical Manufacturing • Boston, Massachusetts, United States • 51-100 Employees
Vaxess Technologies revenue & valuation
| Annual revenue | $11,000,000 |
| Revenue per employee | $193,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $35,200,000 |
| Total funding | $30,000,000 |
Key Contacts at Vaxess Technologies
Rachel Sha
Chief Executive Officer
Himabindu Nandivada
Director Of Process Development
Krishan Kumar
Director, Analytical Development
Jonathan Portman
Associate Director Of Immunology
Matthew Stasio
Associate Director, Lab & Facilities
Matt Manganiello
Director, Rna Delivery
James Ivey
Director Of Process Engineering
Company overview
| Headquarters | 127 Western Avenue, Boston, MA 02134, US |
| Phone number | +16145079586 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Vaccines And Pharmaceuticals |
| Founded | 2012 |
| Employees | 51-100 |
| Socials |
Vaxess Technologies Email Formats
Vaxess Technologies uses 5 email formats. The most common is {first name}{last name} (e.g., johndoe@vaxess.com), used 43.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@vaxess.com | 43.1% |
{first initial} | j@vaxess.com | 29.5% |
{first initial}{last name} | jdoe@vaxess.com | 23.5% |
{last name}{last name} | doedoe@vaxess.com | 3.9% |
About Vaxess Technologies
Vaxess Technologies is transforming home delivery of next generation therapies. Vaxess's platform combines a proprietary microarray patch and applicator, capable of delivering a wide range of therapies. Advanced biomaterials used for the dissolvable microarray tips enable the greatest levels of dose delivery control, and can be modified to deliver different payloads. Additionally, the patch does not require refrigeration, enabling delivery to low resource settings. Vaxess has raised more than $100 million in grant and venture capital funding from groups such as RA Capital Management, Engine Ventures, GHIC, Mission BioCapital, BARDA, DARPA, NIH, NSF and the Gates Foundation. The company has also generated strong clinical and in-vivo proof of concept in the platform with a wide range of molecules. For more information, please visit the company website at www.vaxess.com or send additional inquiries to contact@vaxess.com.Find more information at www.vaxess.com.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Vaxess Technologies has 32 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore Vaxess Technologies's funding history, including investment rounds, total capital raised, and key backers.
Vaxess Technologies Tech Stack
Discover the technologies and tools that power Vaxess Technologies's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
JavaScript libraries
Development
Ecommerce
Security
Hosting
JavaScript frameworks
Security
Miscellaneous
JavaScript libraries
Frequently asked questions
4.8
40,000 users



